Evidence map›Paper›PMID 32820150›Full record

ArticleCell death & disease2020

H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis.

Yanheng Chen, Donald Sheppard, Xingchen Dong, Xiangming Hu, Meihua Chen, Ruichuan Chen, Jayati Chakrabarti, Yana Zavros, Richard M Peek, Lin-Feng Chen

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Frontiers in cell and developmental biology · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Enhancer RNA (eRNA) in Human Diseases.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Yanheng Chen *Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, 61801, IL, USA.
Donald Sheppard *Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, 61801, IL, USA.
Xingchen DongDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, 61801, IL, USA.
Xiangming HuFujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China.
Meihua ChenThe State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, 361101, China.
Ruichuan ChenThe State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, 361101, China.
Jayati ChakrabartiDepartment of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, 45267, OH, USA.
Yana ZavrosDepartment of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, 45267, OH, USA.
Richard M PeekDivision of Gastroenterology, Department of Medicine and Cancer Biology, Vanderbilt University School of Medicine, Nashville, 37232, TN, USA.
Lin-Feng ChenDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, 61801, IL, USA. lfchen@illinois.edu.ORCID http://orcid.org/0000-0003-1809-1580
University of Illinois Urbana-Champaign · USUniversity of Arizona · USXiamen University · CNFujian Medical University · CNVanderbilt University · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
H.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7M
NCI NIH HHS R01 CA077955NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

H. pylori infection is one of the leading causes of gastric cancer and the pathogenicity of H. pylori infection is associated with its ability to induce chronic inflammation and apoptosis resistance. While H. pylori infection-induced expression of pro-inflammatory cytokines for chronic inflammation is well studied, the molecular mechanism underlying the apoptosis resistance in infected cells is not well understood. In this study, we demonstrated that H. pylori infection-induced apoptosis resistance in gastric epithelial cells triggered by Raptinal, a drug that directly activates caspase-3. This resistance resulted from the induction of cIAP2 (encoded by BIRC3) since depletion of BIRC3 by siRNA or inhibition of cIAP2 via BV6 reversed H. pylori-suppressed caspase-3 activation. The induction of cIAP2 was regulated by H. pylori-induced BIRC3 eRNA synthesis. Depletion of BIRC3 eRNA decreased H. pylori-induced cIAP2 and reversed H. pylori-suppressed caspase-3 activation. Mechanistically, H. pylori stimulated the recruitment of bromodomain-containing factor Brd4 to the enhancer of BIRC3 and promoted BIRC3 eRNA and mRNA synthesis. Inhibition of Brd4 diminished the expression of BIRC3 eRNA and the anti-apoptotic response to H. pylori infection. Importantly, H. pylori isogenic cagA-deficient mutant failed to activate the synthesis of BIRC3 eRNA and the associated apoptosis resistance. Finally, in primary human gastric epithelial cells, H. pylori also induced resistance to Raptinal-triggered caspase-3 activation by activating the Brd4-dependent BIRC3 eRNA synthesis in a CagA-dependent manner. These results identify a novel function of Brd4 in H. pylori-mediated apoptosis resistance via activating BIRC3 eRNA synthesis, suggesting that Brd4 could be a potential therapeutic target for H. pylori-induced gastric cancer.

Indexed as

Antigens, BacterialApoptosisBacterial ProteinsBaculoviral IAP Repeat-Containing 3 ProteinBromodomain Containing ProteinsCaspase 3Cell Cycle ProteinsCell Line, TumorEnhancer Elements, GeneticEpithelial CellsGastric MucosaHelicobacter InfectionsHelicobacter pyloriHumansNuclear ProteinsRNA, Long NoncodingAntigens, BacterialBacterial ProteinsBaculoviral IAP Repeat-Containing 3 ProteinBIRC3 protein, humanBRD4 protein, humanBromodomain Containing ProteinsCaspase 3Cell Cycle ProteinsNuclear ProteinsRNA, Long NoncodingTranscription Factors

Identifiers

PMID32820150
PMCPMC7441315
OpenAlexW3073814492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.